Page 51 - Merck Sharp News Today

Observational data show that certain types of sulfonylureas for the treatment of type 2 diabetes are associated with more cardiovascular events compared to other types, such as glimepiride.

$41.7 million in cash and cash equivalents as of September 30, 2022; extends runway through December 2023 Mino-Lok® Phase 3 trial closer to completion with 169...

The prevalence of gastric cancer has been rising since the past few years, which prompts the growing demand for treatment options. The increasing prevalence of cancer, the robust pipeline,

Two vaccines against the Zaire strain of Ebola virus are immunogenic and safe in both adults and children, according to initial results from two phase II clinical trials published in the New England Journal of Medicine.

/PRNewswire/ -- DelveInsights Gastric Cancer Pipeline Insight – 2022 report provides comprehensive global coverage of available, marketed, and pipeline...

Investegate announcements from Moderna Inc, Chantal Friebertsh�user Joins Moderna

MSD Vietnam has hosted a blood donation day, in collaboration with the Red Cross, with the participation of more than 100 employees and their families.

VISTA blockade with HMBD-002 reprograms tumor associated macrophages and promotes cytotoxic T-cell response in preclinical studies HMBD-002 in combination with anti-PD-1 treatment shows enhanced anti-tumor efficacy compared to monotherapy arms in preclinical studies HMBD-002 is currently being assessed in a Phase 1 study to determine the recommended Phase 2 dose as a monotherapy and in combination with pembrolizumab SAN FRANCISCO, HOUSTON and SINGAPORE, Nov. 7, 2022 /PRNewswire/ -- Hummingbird B...

Business Scoop provides news and views on Business and Markets from New Zealand

/PRNewswire/ -- Hangzhou, Zhejiang, China, [December 9th, 2022], Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company...